Related Experiment Video

Updated: Aug 16, 2026

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

[Ketoacidosis in children]

M Nicolino1

  • 1Service d'endocrinologie et diabétologie infantiles, Hôpital Debrousse, Lyon.

La Revue Du Praticien
|March 1, 1996
PubMed

Insights

Diabetic ketoacidosis is a serious diabetes complication causing significant mortality in children, especially when diagnosis is delayed. Prompt treatment involves insulin, electrolyte replacement, and careful rehydration to prevent fatal complications like cerebral edema.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Diabetes Complications

Context:

  • Diabetic ketoacidosis (DKA) is a critical complication of diabetes mellitus in children.
  • Delayed diagnosis and adolescent populations are particularly vulnerable.
  • DKA contributes significantly to pediatric diabetes mortality.

Purpose:

  • To outline the pathophysiology and risk factors of diabetic ketoacidosis in children.
  • To detail the essential components of effective DKA treatment.
  • To emphasize the importance of prompt diagnosis and management.

Summary:

  • DKA presents with significant mortality in pediatric diabetes, often linked to delayed initial diagnosis.
  • Key complications include hypokalemia and cerebral edema, the latter being a primary cause of death.
  • Treatment necessitates understanding pathophysiology, managing risk factors, and includes insulin therapy, early sodium and potassium replacement, gradual rehydration, and intensive monitoring.

Impact:

  • Improved understanding of DKA management can reduce pediatric mortality rates.
  • Highlights the critical need for timely diagnosis and intervention in diabetic children.
  • Provides a framework for evidence-based treatment protocols for DKA in pediatric populations.

More Related Videos

Establishment of an Extracellular Acidic pH Culture System09:41

Establishment of an Extracellular Acidic pH Culture System

Published on: November 19, 2017

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements05:42

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements

Published on: January 7, 2019

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...